Earnings Feed
Start Free
Home/Filings/4/0001225208-26-000702
4//SEC Filing

Weaver Nathan D. 4

Accession 0001225208-26-000702

CIK 0000039368other
View on SEC.govCompany Profile

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 12:43 PM ET

Size

25.5 KB

Accession

0001225208-26-000702

Research Summary

AI-generated summary of this filing

Updated

H.B. Fuller (FUL) Exec VP Nathan Weaver Receives 1,271-Share Award

What Happened
Nathan D. Weaver, Executive Vice President, Business Transformation at H.B. Fuller (FUL), was granted 1,271 restricted stock units (RSUs) on January 20, 2026. The Form 4 reports the award at $0.00 (a grant/award, not a cash purchase). The units are derivative awards that will convert into company common stock if and when they vest.

Key Details

  • Transaction date: 2026-01-20; Form 4 filed: 2026-01-22 (appears filed within the Form 4 reporting window).
  • Reported amount: 1,271 RSUs; reported acquisition price: $0.00 (grant).
  • Vesting: These RSUs vest in three annual installments (33%, 33%, 34%) beginning on the date shown (per footnote F10).
  • Dividend feature: Amount includes RSUs with a dividend-equivalent reinvestment feature (per footnote F11).
  • Shares owned after transaction: Not specified in the provided filing.
  • Footnotes referenced in the filing: F10 (three-year vesting schedule) and F11 (dividend-equivalent reinvestment).

Context
This was an award (grant) of restricted stock units, not an open-market purchase or sale. RSU grants are common as compensation and align executives with long-term stock performance; they do not represent immediately tradable shares until vested and converted. The filing shows a grant value of $0 (typical for awards where no cash was exchanged), and no immediate sale or option exercise was reported.

Insider Transaction Report

Form 4
Period: 2026-01-20
FULLER H B COFUL
Weaver Nathan D.
Exec VP, Business Transform.
Transactions
  • Award

    Performance Stock Units

    [F2][F3]
    2026-01-20+1,271→ 1,271 total
    Exercise: $0.00From: 2026-01-24Exp: 2026-01-24→ Common Stock (1,271 underlying)
Holdings

  • Common Stock

    [F1]
    9,552

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $26.66From: 2021-04-02Exp: 2030-04-02→ Common Stock (9,732 underlying)
    9,732

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $45.05From: 2020-01-24Exp: 2029-01-24→ Common Stock (6,115 underlying)
    6,115

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $48.35From: 2021-01-24Exp: 2030-01-24→ Common Stock (5,362 underlying)
    5,362

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $50.10From: 2018-01-26Exp: 2027-01-26→ Common Stock (4,976 underlying)
    4,976

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $51.89From: 2022-01-27Exp: 2031-01-27→ Common Stock (11,992 underlying)
    11,992

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $53.57From: 2019-01-25Exp: 2028-01-25→ Common Stock (4,585 underlying)
    4,585

  • Employee Stock Option (Right-to-Buy)

    [F5]
    Exercise: $64.28From: 2026-01-27Exp: 2035-01-27→ Common Stock (14,844 underlying)
    14,844

  • Employee Stock Option (Right-to-Buy)

    [F5]
    Exercise: $68.17From: 2024-01-24Exp: 2033-01-24→ Common Stock (9,634 underlying)
    9,634

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $72.94From: 2023-01-24Exp: 2032-01-24→ Common Stock (8,249 underlying)
    8,249

  • Employee Stock Option (Right-to-Buy)

    [F5]
    Exercise: $77.72From: 2025-01-26Exp: 2034-01-26→ Common Stock (9,806 underlying)
    9,806

  • Phantom Units

    [F6][F7][F8]
    Exercise: $0.00→ Common Stock (5,895.44 underlying)
    5,895.44

  • Restricted Stock Units

    [F9][F10][F11]
    Exercise: $0.00From: 2024-01-24Exp: 2026-01-24→ Common Stock (562.91 underlying)
    562.91

  • Restricted Stock Units

    [F9][F10][F11]
    Exercise: $0.00From: 2025-01-26Exp: 2027-01-26→ Common Stock (1,129.28 underlying)
    1,129.28

  • Restricted Stock Units

    [F9][F10][F11]
    Exercise: $0.00From: 2026-01-27Exp: 2028-01-27→ Common Stock (2,640.43 underlying)
    2,640.43
Footnotes (11)
  • [F1]Amount includes shares acquired pursuant to a dividend reinvestment plan.
  • [F10]These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.
  • [F11]Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.
  • [F2]These performance stock units convert into shares of common stock on a 1-for-1 basis.
  • [F3]Each performance stock unit represents a contingent right to receive one share of H.B. Fuller common stock on the vesting date of January 24, 2026. This amount represents H.B. Fuller achieving return on invested capital payout at 80% of the target level.
  • [F4]This option is 100% vested.
  • [F5]This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.
  • [F6]These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.
  • [F7]These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
  • [F8]Amount includes stock units acquired pursuant to a dividend equivalent feature.
  • [F9]These restricted stock units convert into shares of common stock on a 1-for-1 basis.
Signature
/s/ Patrick J. Seul, Attorney-in-Fact|2026-01-22

Documents

1 file

Issuer

FULLER H B CO

CIK 0000039368

→
Entity typeother

Related Parties

1
  • filerCIK 0001807831

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 12:43 PM ET
Size
25.5 KB
View on SEC.gov